Multipurpose central venous access in the immunocompromised pediatric patient

Paul M. Colombani, David L. Dudgeon, James R. Buck, David M. Miller, Mary jo Ghory, Colleen Buckloo, J. Alex Haller

Research output: Contribution to journalArticle

Abstract

During a 21-month period, 50 consecutive pediatric oncology patients undergoing bone marrow transplantation and/or cytoreductive chemotherapy had 61 silastic central venous catheters placed to facilitate their therapy. All catheters were used for medications, routine blood sampling, and transfusions, with 45% also used for hyperalimentation and 57% used for bone marrow transplantation. Catheters were utilized during both inpatient and outpatient therapy periods. Total catheter days numbered 8455, an average of 139 days per catheter. Forty-seven catheters (77%) were removed electively or were in place at time of patient death. Seven were removed for mechanical complications (1/1409 catheter days). Four additional episodes of presumed catheter sepsis were managed with antibiotics and did not require catheter removal (40% of septic episodes). One catheter is still in place after 585 days. Complication rates were not influenced by this multiple use protocol. With standardized catheter care and surveillance, multipurpose, long-term central venous access can be safely utilized in the immunosuppressed pediatric patient. (Journal of Parenteral and Enteral Nutrition 9:38-41, 1985).

Original languageEnglish (US)
Pages (from-to)38-41
Number of pages4
JournalJournal of Parenteral and Enteral Nutrition
Volume9
Issue number1
DOIs
StatePublished - Jan 1985

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Fingerprint Dive into the research topics of 'Multipurpose central venous access in the immunocompromised pediatric patient'. Together they form a unique fingerprint.

  • Cite this